Why Is Coeptis Therapeutics Stock Falling On Friday?
| COEP Stock | USD 9.38 0.07 0.75% |
Slightly above 55% of Coeptis Therapeutics' retail investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Coeptis Therapeutics suggests that some traders are interested. Coeptis Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Coeptis Therapeutics. Many technical investors use Coeptis Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Coeptis |
Coeptis Therapeutics Holdings, Inc. shares are trading lower on Friday. The firm announced plans to implement a 1-for-20 reverse stock split, which will take effect on December 31. The decision follows authorization from the companys board of directors and majority stockholders. The reverse stock split aims to help the company meet the Nasdaq Capital Markets minimum bid price requirement of 1.00 per share, which is necessary to maintain its listing on the exchange. Also Read 3
Read at finance.yahoo.com
 |
Coeptis Therapeutics Fundamental Analysis
We analyze Coeptis Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coeptis Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coeptis Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Coeptis Therapeutics is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Coeptis Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Coeptis Therapeutics stock to make a market-neutral strategy. Peer analysis of Coeptis Therapeutics could also be used in its relative valuation, which is a method of valuing Coeptis Therapeutics by comparing valuation metrics with similar companies.
Peers
Coeptis Therapeutics Related Equities
| CING | Cingulate | 5.07 | ||||
| CMND | Clearmind Medicine | 1.90 | ||||
| GNLX | Genelux Common | 1.65 | ||||
| DYAI | Dyadic International | 1.48 | ||||
| ALLR | Allarity Therapeutics | 0.95 | ||||
| PALI | Palisade Bio | 1.43 | ||||
| SONN | Sonnet Biotherapeutics | 1.50 | ||||
| REVB | Revelation Biosciences | 2.17 | ||||
| MNPR | Monopar Therapeutics | 2.56 | ||||
| ZVSA | ZyVersa Therapeutics | 12.86 | ||||
| QNRX | Quoin Pharmaceuticals | 14.29 | ||||
| ADTX | Aditxt | 18.96 | ||||
| ICU | LMF Acquisition | 22.73 | ||||
| PSTV | Plus Therapeutics | 23.68 |
Additional Tools for Coeptis Stock Analysis
When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.